Targeting Anxiety to Improve Sleep Disturbance: A Randomized Clinical Trial of App-Based Mindfulness Training.
Open accessAbstract
Objective: Sleep disturbance is experienced by nearly 20% of Americans and is highly comorbid with anxiety. Sleep disturbances may predict the development of anxiety disorders. Mindfulness training (MT) has shown efficacy for anxiety yet remains limited by in-person-based delivery. Digitally delivered MT may target habitual worry processes, yet its effects on sleep have not been studied. This study tested if app-based MT for anxiety could reduce worry and improve sleep and examined the underlying mechanisms. Methods: Individuals reporting worry interfering with sleep were randomized to treatment as usual (TAU; n = 40) or TAU + app-based MT (n = 40). Treatment-related changes in worry-related sleep disturbances (WRSDs), worry, nonreactivity, and anxiety were evaluated via self-report questionnaires at 1 and 2 months after treatment initiation. Fitbit devices were used to record total sleep time and estimate sleep efficiency. At 2 months, TAU received access to app-based MT, and both groups were reassessed at 4 months. Results: In a modified intent-to-treat analysis, WRSD scores decreased by 27% in TAU + MT (n = 36) and 6% in TAU (n = 35) at 2 months (median [IQR] change = 11 [4.3] versus 15 [5.0], p = .001). These WRSD reductions were mediated by decreased worry, particularly improved nonreactivity (p values < .001). At 4 months, TAU reported a significant 29% reduction after beginning app-based MT at 2 months and TAU + MT maintained its gains. No significant between-group differences in average estimated total sleep time or sleep efficiency were found after 2 months of using the app. Conclusions: Few mindfulness-related apps have been evaluated for clinical efficacy and/or mechanism. Results from this study demonstrate a mechanistic link between MT and increased emotional nonreactivity, decreased worry, and reduction in reported sleep disturbances, suggesting that app-based MT may be a viable option to help individuals who report that worry interferes with their sleep. Trial Registration: ClinicalTrials.gov identifier: NCT03684057.
AI snapshot
Written from the paper’s full text.
TL;DR
In adults reporting worry that interfered with sleep, adding an app-based mindfulness program to usual care reduced worry-related sleep disturbance, worry, and anxiety more than usual care alone over two months, with gains maintained and reproduced when controls later received the app. Mediation analyses suggested increased emotional non-reactivity lowered worry, which in turn lowered perceived sleep disturbance, while device-estimated sleep duration and efficiency did not differ between groups.
Key findings
- At 2 months, worry-related sleep disturbance fell by 27% with TAU+MT versus 6% with TAU; PROMIS scores dropped from 16.5 to 11.0 versus 16.0 to 15.0 (P = .001). After TAU received the app at 2 months, it showed a 29% reduction by 4 months, while TAU+MT maintained its gains.
- Worry decreased by 12% in TAU+MT versus 0.3% in TAU (PSWQ: 62.3 to 54.6 vs. 62.3 to 61.7, P < .001); non-reactivity increased by 27% versus 4% (P < .001); anxiety showed a median 37% reduction versus a 17% increase (GAD-7: 12.0 to 6.5 vs. 10.0 to 11.0, P = .002).
- Mediation models indicated that increased non-reactivity at 2 months mediated the effect of MT on reduced worry (indirect β = −0.43, 95% CI −0.77 to −0.18, P < .001; 49% of the effect), and reduced worry fully mediated the effect on WRSD (indirect β = −0.39, 95% CI −0.69 to −0.15, P < .001; 53% of the effect).
- No significant between-group differences appeared in Fitbit-estimated total sleep time or sleep efficiency at 2 months (P = .52; P = .70), or in sleep-diary sleep period time (P = .75).
Methods
- Parallel-group randomized controlled trial: 80 adults with elevated worry and self-reported worry-related sleep trouble were randomized 1:1 to TAU (n = 40) or TAU plus app-based MT (n = 40); 71 entered the modified intent-to-treat analysis (TAU+MT n = 36; TAU n = 35).
- The intervention was the Unwinding Anxiety app: 30 core modules plus 8 theme weeks, brief daily videos/animations, ecological momentary assessment tools, guided meditations, and short on-demand exercises; the program lasted 2 months, with assessments at baseline, 1, 2, and 4 months, and TAU receiving app access after the 2-month assessment.
- Primary outcome was WRSD from five PROMIS sleep disturbance items; secondary outcomes included PSWQ worry, FFMQ non-reactivity, GAD-7 anxiety, Fitbit TST/SE, and paper sleep diaries. Analyses used intent-to-treat and complete-case approaches, GEE models, multiple imputation, and Baron-and-Kenny plus causal mediation models with bootstrapping.
Limitations
- Stated: the commercial Fitbit has accuracy and precision limits, tends to overestimate total sleep time and underestimate restlessness, and the study did not clinically evaluate insomnia, so findings may not generalize to chronic insomnia; the PROMIS items focus on worry at bedtime and difficulty falling asleep, leaving sleep onset latency, awakenings, and wake after sleep onset for future work.
- Stated: the trial lacked an active control matched for cognitive effort, and future research should compare digital CBT-I with digital MT because they target sleep-related worry and behavior through different mechanisms.
- Evident from the text: baseline Fitbit sleep efficiency was already 96% in both groups, suggesting a ceiling effect; missing data were substantial (about 30% for Fitbit wear periods and 9.3% for sleep diaries), and engagement was incomplete (53% of TAU+MT completed 30 modules at 2 months, rising to 73% at 4 months; 34% of TAU completed the program by 4 months).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
15 of 45 cited sources checked · 9 supported · 0 flagged · accuracy not yet measured
- Premisecitation
Mindfulness-based Stress Reduction is a promising intervention to mitigate anxiety.
“Mindfulness-based Stress Reduction (MBSR), is a promising intervention to mitigate anxiety (9).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [9] source
- Premisecitation
The effects of mindfulness training on anxiety were mediated by decreased worry.
“Furthermore, the effects of MT on anxiety were mediated by decreased worry.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [18] source
- Premisecitation
Improving the ability to maintain emotional non-attachment from unfavorable sleep outcomes through mindfulness practice addresses the metacognitive component of sleep-related arousal.
“Improving one’s ability to maintain emotional non-attachment from unfavorable sleep outcomes through mindfulness practice addresses the metacognitive component of sleep-related arousal (11,13,14).”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [11] source
- cites [13] source
The Secondary outcomes discussion says mindfulness may promote cognitive deactivation by helping people disengage from concerns and relate to sleep-related thoughts with letting go and acceptance. The Changes in study outcomes section also reports reduced cognitive pre-sleep arousal with the mindfulness app. Neither passage specifically establishes emotional non-attachment from unfavorable sleep outcomes as the mechanism or identifies a metacognitive component of arousal. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [14] source
- Premisecitation
Developing metacognitive awareness may help individuals notice body sensations and hyperarousal without worsening inability to sleep due to frustration.
“Developing metacognitive awareness may help individuals to notice body sensations and hyperarousal without exacerbating the inability to sleep due to frustration (11).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [11] source
- Premisecitation
In previous research, app-based mindfulness training significantly reduced anxiety in individuals with generalized anxiety disorder.
“In previous research, app-based MT was shown to significantly reduce anxiety in individuals with GAD (18).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [18] source
- Premisecitation
A previous study of MT for reducing anxiety in individuals with GAD demonstrated that the mediation effect of worry was greater at 2 months than at 1 month.
“Our previous study of MT for reducing anxiety in individuals with GAD demonstrated that the mediation effect of worry was greater at 2 months than at 1 month (18).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [18] source
- Findingown data
No significant time effect on WRSD was found in the TAU group.
“A GEE model found a significant time effect for TAU + MT at 1 (β = 3.2, SE = 0.78, P < .001) and 2 months (β = 4.7, SE = 0.79, P < .001) while no effect was found in TAU.”
Quote in the paperSubstantial claim - Findingown data
The reductions in worry-related sleep disturbance were mediated by decreased worry, especially by improved non-reactivity, with P values below .001.
“These WRSD reductions were mediated by decreased worry, particularly improved non-reactivity (P’s < .001).”
Quote in the paperSubstantial claim - Findingown data
No adverse events related to the intervention were reported in either group.
“There were no adverse events related to the intervention reported in either group.”
Quote in the paperNot a substantial claim - Findingown data
At 2 months, the TAU + MT group showed a median reduction of 27% in WRSD compared with 6% in the TAU group (P = .001).
“At 2 months, the TAU + MT group demonstrated a median reduction of 27% in WRSD compared to a reduction of 6% in the TAU group; the score dropped from 16.5 to 11.0 and 16.0 to 15.0 respectively (P = .001; see Figure 3A).”
Quote in the paperSubstantial claim - Findingown data
A Wilcoxon signed rank test found a median reduction of 5 (29%) in WRSD score in the TAU group after receiving the intervention in months 2 to 4 (P < .001; Padj < .001).
“A Wilcoxon signed rank test found a median reduction of 5 (29%) in WRSD score in the TAU group after receiving the intervention in months 2 to 4 of the study (P < .001; Padj < .001), and the original treatment group maintained its improvement.”
Quote in the paperSubstantial claim - Findingown data
After 2 months of app use, there were no significant between-group differences in average estimated total sleep time or sleep efficiency.
“No significant between-group differences in average estimated TST or SE were found after 2 months of using the app.”
Quote in the paperSubstantial claim- Rests on an assumption: Fitbit-derived estimates of total sleep time and sleep efficiency are accurate enough to detect between-group differences in sleep outcomes.
- Findingown data
At 4 months, the TAU group reported a significant 29% reduction after starting app-based mindfulness training at 2 months.
“At 4 months, TAU reported a significant 29% reduction after beginning app-based MT at 2 months”
Quote in the paperSubstantial claim - Findingown data
At 2 months, there was a significant GROUP X TIME interaction for WRSD (β = −3.0, SE = 0.95, P = .002).
“At 2 months, there was a significant GROUP X TIME interaction (β = −3.0, SE = 0.95, P = .002; see Figure 4A).”
Quote in the paperSubstantial claim - Findingown data
At 4 months, the TAU+MT group maintained its gains.
“and TAU+MT maintained its gains.”
Quote in the paperSubstantial claim - Findingown data
A GEE model found a significant time effect for TAU + MT on WRSD at 2 months (β = 4.7, SE = 0.79, P < .001).
“A GEE model found a significant time effect for TAU + MT at 1 (β = 3.2, SE = 0.78, P < .001) and 2 months (β = 4.7, SE = 0.79, P < .001) while no effect was found in TAU.”
Quote in the paperSubstantial claim - Findingown data
A GEE model found a significant time effect for TAU + MT on WRSD at 1 month (β = 3.2, SE = 0.78, P < .001).
“A GEE model found a significant time effect for TAU + MT at 1 (β = 3.2, SE = 0.78, P < .001) and 2 months (β = 4.7, SE = 0.79, P < .001) while no effect was found in TAU.”
Quote in the paperSubstantial claim - Findingown data
After controlling for reduction in worry, MT was no longer significantly associated with reduction in worry (P = .13).
“MT was no longer associated with reduction in worry (P = .13).”
Quote in the paperSubstantial claim - Findingown data
No significant time effects on PSWQ were found in the TAU group.
“A GEE model demonstrated a significant time effect for TAU + MT at 1 (β = −3.6, SE = 1.03, P < .001) and 2 months (β = −7.6, SE = 1.33, P < .001) while no effects were found in TAU.”
Quote in the paperSubstantial claim - Findingown data
MT was not significantly associated with increases in non-reactivity at 1 month (β = 0.11, SE = 0.25, P = .67).
“However, MT was not significantly associated with increases in non-reactivity at 1 month (β = 0.11, SE = 0.25, P = .67).”
Quote in the paperSubstantial claim - Findingown data
MT was significantly associated with a reduction in WRSD at 2 months, controlling for gender, with a total effect of β = −0.76 (SE = 0.23, P = .002).
“MT was significantly associated with a reduction in WRSD post treatment with a total effect of β = −0.76 (SE = 0.23, P = .002).”
Quote in the paperSubstantial claim - Findingown data
At 2 months, the TAU + MT group showed an average reduction of 12% in PSWQ score compared with 0.3% in the TAU group (P < .001).
“At 2 months, the TAU + MT group demonstrated an average reduction of 12% in PSWQ score (worry) relative to a reduction of 0.3% in the TAU group; with a change (Δ) from 62.3 to 54.6 and 62.3 to 61.7 respectively (P < .001; see Figure 3B).”
Quote in the paperSubstantial claim - Findingown data
At 2 months, MT was significantly related to increases in non-reactivity (β = 0.87, SE = 0.23, P < .001).
“Results indicated that at 2 months, MT was significantly related to increases in non-reactivity (β = 0.87, SE = 0.23, P < .001), allowing us to proceed to Step 3 (Fig. 5A, a path).”
Quote in the paperSubstantial claim - Findingown data
MT was not associated with a significant reduction in worry at 1 month (P = .11).
“However, MT was not associated with a significant reduction in worry, so further analyses were not performed (P = .11).”
Quote in the paperSubstantial claim - Findingown data
At 2 months, there was a significant GROUP X TIME interaction for non-reactivity (β = 3.8, SE = 0.78, P < .001).
“At 2 months, there was also a significant GROUP X TIME interaction (β = 3.8, SE = 0.78, P < .001; see Figure 4C).”
Quote in the paperSubstantial claim - Findingown data
No significant effects of time on GAD-7 were found in the TAU group.
“A GEE model found a significant effect of time for TAU + MT (1 month: β = −1.9, SE = 0.90, P = .03; 2 months: β = −4.0, SE = 0.87, P < .001) while no effects were found in the TAU group.”
Quote in the paperSubstantial claim - Findingown data
At 2 months, there was a significant between-group difference in anxiety: TAU + MT reported a median reduction of 37% in GAD-7 score compared with an increase of 17% in TAU (P = .002).
“At 2 months, we found a significant between-group difference in anxiety: the TAU + MT group reported a median reduction of 37% in GAD-7 score compared to an increase of 17% in TAU. In TAU + MT, the score dropped from 12.0 to 6.5 while it increased from 10.0 to 11.0 in TAU (P = .002; see Figure 3D).”
Quote in the paperSubstantial claim - Findingown data
At 2 months, MT was significantly related to reduction in worry (β = −0.86, SE = 0.23, P < .001).
“Assessing change at 2 months, MT was significantly related to reduction in worry (β = −0.86, SE = 0.23, P < .001; Fig. 5B, a path).”
Quote in the paperSubstantial claim - Findingown data
After receiving the app at 2 months, the TAU group reported a median reduction of 3 (33%) in GAD-7 score at 4 months (P < .001; Padj < .001).
“After receiving the app at 2 months, the TAU group reported a significant median reduction of 3 (33%) in GAD-7 score at 4 months (P < .001; Padj < .001), while the original treatment group maintained its improvements.”
Quote in the paperSubstantial claim - Findingown data
At 2 months, TAU + MT reported an average increase of 27% in non-reactivity score compared with 4% in the TAU group (P < .001).
“At 2 months, TAU + MT reported an average increase of 27% in non-reactivity score relative to an increase of 4% in the TAU group (TAU + MT Δ - 17.8 to 21.7 vs. TAU Δ - 17.0 to 21.5, P < .001; see Figure 3C).”
Quote in the paperSubstantial claim - Findingown data
In the complete-case analysis (49 participants), no significant between-group differences in average reported SPT were found at 2 months (P = .76).
“49 participants were included in CC analysis and at 2 months, no significant between-group differences in average reported SPT were found (P = .76; see Appendix 2, Supplemental Digital Content 2).”
Quote in the paperNot a substantial claim - Findingown data
After treatment initiation at 2 months, the TAU group reported an average increase of 3.9 (28%) in non-reactivity score at 4 months (P < .001; Padj < .001).
“After treatment initiation at 2 months, the TAU group reported a significant 3.9 (28%) average increase in non-reactivity score at 4 months (P < .001; Padj < .001), while the original treatment group maintained its improvements.”
Quote in the paperNot a substantial claim - Findingown data
The relationship between MT and reduction in worry from baseline to 2 months was significantly mediated by increases in non-reactivity (Sobel test z' = −2.99, P = .003).
“The Sobel test was used to formally test the indirect effect (product of a and b path coefficients: .87 x −.49 = −0.43), which found that from baseline to 2 months, the relationship between MT and reduction in worry was significantly mediated by increases in non-reactivity (z’ = −2.99, P = .003).”
Quote in the paperSubstantial claim - Findingown data
There was a significant GROUP X TIME effect on PSWQ at 2 months (β = −6.4, SE = 1.89, P < .001).
“There was also a significant GROUP X TIME effect at 2 months (β = −6.4, SE = 1.89, P < .001; see Figure 4B).”
Quote in the paperSubstantial claim - Findingown data
No significant time effects on non-reactivity were found for the TAU group.
“At 2 months, a GEE model found a significant time effect for TAU + MT (β = 4.0, SE = 0.71, P < .001). No effects were found for TAU.”
Quote in the paperNot a substantial claim - Findingown data
The relationship between MT and reduction in worry was partially mediated by increases in non-reactivity at 2 months, with an estimated indirect effect of β = −0.43 (95% CI: −.77 to −.18, P < .001).
“The relationship between MT and reduction in worry was partially mediated by increases in non-reactivity at 2 months with an estimated indirect effect of β = −0.43 (95% CI: −.77 to −.18, P < .001).”
Quote in the paperSubstantial claim - Findingown data
There was a significant GROUP X TIME interaction for GAD-7 at 2 months (β = −3.0, SE = 1.06, P = .004).
“There was also a significant GROUP X TIME interaction at 2 months (β = −3.0, SE = 1.06, P = .004; see Figure 4D).”
Quote in the paperSubstantial claim - Findingown data
A GEE model demonstrated a significant time effect for TAU + MT on PSWQ at 2 months (β = −7.6, SE = 1.33, P < .001).
“A GEE model demonstrated a significant time effect for TAU + MT at 1 (β = −3.6, SE = 1.03, P < .001) and 2 months (β = −7.6, SE = 1.33, P < .001) while no effects were found in TAU.”
Quote in the paperSubstantial claim - Findingown data
A GEE model found a significant effect of time for TAU + MT on GAD-7 at 2 months (β = −4.0, SE = 0.87, P < .001).
“A GEE model found a significant effect of time for TAU + MT (1 month: β = −1.9, SE = 0.90, P = .03; 2 months: β = −4.0, SE = 0.87, P < .001) while no effects were found in the TAU group.”
Quote in the paperSubstantial claim - Findingown data
There was an average estimated increase in TST from 432 to 437 minutes in TAU + MT (n=33) compared with an increase from 427 to 437 minutes in TAU (n=31).
“There was an average estimated increase in TST from 432 to 437 minutes in TAU + MT (n=33) compared to an increase from 427 to 437 minutes in TAU (n=31).”
Quote in the paperNot a substantial claim - Findingown data
Reduction in worry at 2 months exhibited a significant direct effect on WRSD post-intervention (β = 0.46, SE = 0.11, P < .001).
“We evaluated whether the mediator at 2 months led to significant reductions in WRSD and found that reduction in worry at 2 months exhibited a significant direct effect on WRSD post-intervention (β = 0.46, SE = 0.11, P < .001; Fig. 5B, b path).”
Quote in the paperSubstantial claim - Findingown data
After imputing missing data, no significant between-group differences were found in any sleep measures at 2 months post treatment initiation (P = .75).
“After imputing missing data, no significant between-group differences were found in any sleep measures at 2 months post treatment initiation (P = .75).”
Quote in the paperSubstantial claim - Findingown data
After receiving the intervention at 2 months, the TAU group reported an average reduction of 8.4 (13%) in PSWQ score at 4 months (P < .001; Padj < .001).
“After receiving the intervention at 2 months, the TAU group reported a similar 8.4 (13%) average reduction in PSWQ score at 4 months (P < .001; Padj < .001), while the original treatment group maintained its improvements.”
Quote in the paperSubstantial claim - Findingown data
A GEE model found a significant time effect for TAU + MT on non-reactivity at 2 months (β = 4.0, SE = 0.71, P < .001).
“At 2 months, a GEE model found a significant time effect for TAU + MT (β = 4.0, SE = 0.71, P < .001). No effects were found for TAU.”
Quote in the paperSubstantial claim - Findingown data
The relationship between MT and reduction in WRSD at 2 months was significantly mediated by a reduction in worry (Sobel test z' = −2.82, P = .005).
“The Sobel test was used to formally test the indirect effect (ab = −0.39), which found that at 2 months, the relationship between MT and reduction in WRSD was significantly mediated by a reduction in worry (z’ = −2.82, P = .005).”
Quote in the paperSubstantial claim - Findingown data
Non-reactivity was significantly related to reductions in worry at 2 months (β = −0.49, SE = 0.11, P < .001).
“Non-reactivity was found to be significantly related to reductions in worry at 2 months (β = −0.49, SE = 0.11, P < .001).”
Quote in the paperSubstantial claim - Findingown data
Using causal mediation, the estimated direct effect of MT on reduction in WRSD was β = −0.36 (95% CI: −.86 to .12, P = .11).
“Using the causal mediation approach, we found the estimated direct effect of MT on reduction in WRSD was β = −0.36 (95% CI: −.86 to .12, P = .11).”
Quote in the paperSubstantial claim - Findingown data
Increases in non-reactivity scores at 1 month did not mediate the effect of MT on reduction in worry.
“This is also reflected in our mediation models, as increases in non-reactivity scores at 1 month did not mediate the effect of MT on reduction in worry.”
Quote in the paperNot a substantial claim - Findingown data
The original treatment group maintained its improvements in non-reactivity.
“After treatment initiation at 2 months, the TAU group reported a significant 3.9 (28%) average increase in non-reactivity score at 4 months (P < .001; Padj < .001), while the original treatment group maintained its improvements.”
Quote in the paperNot a substantial claim - Findingown data
The original treatment group maintained its improvements in PSWQ.
“After receiving the intervention at 2 months, the TAU group reported a similar 8.4 (13%) average reduction in PSWQ score at 4 months (P < .001; Padj < .001), while the original treatment group maintained its improvements.”
Quote in the paperSubstantial claim - Findingown data
A GEE model demonstrated a significant time effect for TAU + MT on PSWQ at 1 month (β = −3.6, SE = 1.03, P < .001).
“A GEE model demonstrated a significant time effect for TAU + MT at 1 (β = −3.6, SE = 1.03, P < .001) and 2 months (β = −7.6, SE = 1.33, P < .001) while no effects were found in TAU.”
Quote in the paperSubstantial claim - Findingown data
The effects of MT on percent change in WRSD, worry, and non-reactivity scores were reproduced by the TAU group while maintaining expected directionality.
“The effects of MT on percent change in WRSD, worry, and non-reactivity scores were reproduced by the TAU group while maintaining expected directionality.”
Quote in the paperSubstantial claim - Findingown data
Using causal mediation analysis, the direct effect of MT on reduction in worry at 2 months was β = −0.44 (95% CI: −.84 to −.02, P = .04).
“Using this approach, the direct effect of MT on reduction in worry at 2 months was estimated to be β = −0.44 (95% CI: −.84 to −.02, P = .04; Fig. 5A, c’ path).”
Quote in the paperSubstantial claim - Findingown data
The original treatment group maintained its improvement in WRSD.
“A Wilcoxon signed rank test found a median reduction of 5 (29%) in WRSD score in the TAU group after receiving the intervention in months 2 to 4 of the study (P < .001; Padj < .001), and the original treatment group maintained its improvement.”
Quote in the paperSubstantial claim - Findingown data
Reduction in worry at 2 months fully mediated the relationship between MT and reduction in WRSD, with an estimated indirect effect of β = −0.39 (95% CI: −.69 to −.15, P < .001).
“Reduction in worry at 2 months fully mediated the relationship between MT and reduction in WRSD with an estimated indirect effect of β = −0.39 (95% CI: −.69 to −.15, P < .001; see Fig. 5B, c’ path).”
Quote in the paperSubstantial claim - Findingown data
MT was significantly associated with reduction in worry at 2 months, controlling for gender, with a total effect of β = −0.86 (SE = 0.23, P < .001).
“MT was significantly associated with reduction in worry at 2 months with a total effect of β = −0.86 (SE = 0.23, P < .001).”
Quote in the paperSubstantial claim - Findingown data
The original treatment group maintained its improvements in GAD-7.
“After receiving the app at 2 months, the TAU group reported a significant median reduction of 3 (33%) in GAD-7 score at 4 months (P < .001; Padj < .001), while the original treatment group maintained its improvements.”
Quote in the paperSubstantial claim - Findingown data
After controlling for increases in non-reactivity, MT was no longer significantly associated with reduction in worry (P = .05).
“MT was no longer associated with reduction in worry (P = .05).”
Quote in the paperSubstantial claim - Findingown data
A GEE model found a significant effect of time for TAU + MT on GAD-7 at 1 month (β = −1.9, SE = 0.90, P = .03).
“A GEE model found a significant effect of time for TAU + MT (1 month: β = −1.9, SE = 0.90, P = .03; 2 months: β = −4.0, SE = 0.87, P < .001) while no effects were found in the TAU group.”
Quote in the paperSubstantial claim - Premisecitation
A lack of trained practitioners limits patient access to cognitive behavioral treatment of insomnia.
“but lack of trained practitioners’ limits patient access (17).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] source
- Premisecitation
Digital therapeutics have the potential to increase access to mental health treatment through relatively low cost, ready access, and high treatment fidelity.
“Digital therapeutics have the potential to increase access to mental health treatment by virtue of relatively low cost, ready access, and high treatment fidelity as has been demonstrated through successful digital delivery of CBT-I (find studies).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites find studies
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Mindfulness training increases metacognitive awareness, the ability to monitor and control one's own cognition to disrupt cycles of worry.
“Mindfulness training (MT) increases metacognitive awareness, which is defined as the ability to monitor and control one’s own cognition to disrupt cycles of worry (12).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12] source
- Premisecitation
High levels of worry predict more sleep problems, including increased nocturnal awakenings and lower sleep efficiency.
“High levels of worry predict more sleep problems such as increased nocturnal awakenings and lower sleep efficiency (7).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] source
- Interpretationreasoning
Because participants were not clinically evaluated for insomnia during recruitment, they are more representative of a broader non-clinical population with sleep disturbances.
“During recruitment, individuals were not clinically evaluated for insomnia and thus are more representative of a broader non-clinical population who experience sleep disturbances.”
Quote in the paperNot a substantial claim - Interpretationown data
App-based mindfulness training may be a viable option for people who report that worry interferes with their sleep.
“suggesting that app-based MT may be a viable option to help individuals who report that worry interferes with their sleep.”
Quote in the paperSubstantial claim - Premisecitation
Anxiety-specific treatments are less effective when sleep disturbance is not addressed.
“Moreover anxiety-specific treatments are less effective when sleep disturbance is not addressed (3).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] source
- Study design and conductcitation
Five PROMIS Sleep Disturbance items that directly assess worry's impact on sleep were validated for independent use to measure worry-related sleep disturbance.
“Five items from the PROMIS Sleep Disturbance item bank that directly evaluate the impact of worry on sleep, validated for independent use, were used to assess WRSD (28,32).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Worry plays a major role in increasing bedtime arousal and perceived sleep disturbances.
“worry plays a major role in increasing bedtime arousal and perceived sleep disturbances (4).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [4] source
- Study design and conductown data
The evaluation of an app-based MT program leverages a unique study design for replication of effect sizes within the same study.
“Our evaluation of an app-based MT program leverages a unique study design for replication of effect sizes within the same study.”
Quote in the paperSubstantial claim - Interpretationown data
Sustained MT is necessary to have an effect on non-reactivity.
“This suggests that, while there is a trend toward significance at 1 month, sustained MT is necessary to have an effect on non-reactivity.”
Quote in the paperSubstantial claim - Interpretationnone given
Using a commercial device to measure sleep comes with limitations in accuracy and precision.
“Using a commercial device to measure sleep comes with limitations in accuracy and precision.”
Quote in the paperSubstantial claim - Interpretationown data
These results provide evidence of efficacy that progresses app-based MT for worry and sleep beyond Stage I studies and toward efficacy and implementation research.
“These results provide evidence of efficacy that progresses app-based MT for worry and sleep beyond Stage I studies and toward efficacy and implementation research.”
Quote in the paperSubstantial claim - Interpretationown data
Mechanistically-based and targeted MBIs may be a helpful addition to other therapies for sleep disturbances.
“Given the results of this study, mechanistically-based and targeted MBIs may be a helpful addition to the other therapies that exist for sleep disturbances.”
Quote in the paperSubstantial claim - Interpretationreasoning
Because the study did not screen participants for clinically diagnosed insomnia, lower precision presents less of a limitation compared to if a clinical population had been recruited.
“Because our study did not screen participants for clinically diagnosed insomnia, lower precision presents less of a limitation compared to if we had recruited a clinical population.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Since the participant population was not clinically evaluated for insomnia, MT in this study is likely targeting worry to improve perceived inadequacies of sleep in a broader population experiencing sub-clinical sleep difficulties.
“Since our participant population was not clinically evaluated for insomnia, MT in this study is likely targeting worry to improve perceived inadequacies of sleep in a broader population experiencing sub-clinical sleep difficulties.”
Quote in the paperSubstantial claim- Rests on an assumption: Sleep disturbances and worry about sleep affect many people at a severity that does not always warrant a clinical diagnosis.
- Study design and conductown data
Using Cochrane Collaboration's criteria, the study was found to have low risk of bias in all 7 categories.
“Using Cochrane Collaboration’s criteria for evaluating bias (41), we found a low risk of bias in all 7 categories.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] source
- Interpretationown data
These findings suggest the potential utility of app-based MT to help individuals with anxiety and WRSD.
“These findings suggest the potential utility of app-based MT to help individuals with anxiety and WRSD.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 24
- May combine two claims. 33
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductcitationThe Generalized Anxiety Disorder-7 is a validated 7-item questionnaire with sensitivity 89% and specificity 82% for screening generalized anxiety disorder and assessing symptom severity.
“The GAD-7 is a validated 7-item questionnaire used clinically to screen for GAD and assess symptom severity (sensitivity of 89%, specificity of 82%) (33).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [33] source
The Scientific considerations section discusses patient self-reports for rheumatoid arthritis, and the Definitions section discusses validation generally. Neither addresses the GAD-7. Searches for GAD-7, anxiety screening, and the stated sensitivity and specificity found no passage in our copy supporting the claim. (LLM, conf=0.76)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationThe intervention content is based on a framework from previously developed in-person and app-based mindfulness training protocols that share reinforcement learning as a core mechanism and have produced clinically meaningful outcomes.
“The intervention content is based on a framework from previously developed in-person and app-based MT protocols that share a core underlying mechanism (reinforcement learning) that have yielded clinically meaningful outcomes (e.g., cessation of smoking and overeating) (24–27).”
Quote in the paperNot a substantial claim2 of 4 sources checked- cites [24] source
- cites [25] source
The Introduction (page unavailable) says the smartphone smoking-cessation app was based on an efficacious in-person mindfulness program, and reports higher abstinence rates in a prior in-person trial. The copy does not identify reinforcement learning as a shared mechanism or address overeating outcomes. Its Primary Outcome section (page unavailable) reports no improvement in smoking abstinence for the app versus control. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [26] source
- cites [27]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Study design and conductreasoningA sample of 64 would have 80% power for non-reactivity and 83% power for worry-related sleep disturbance to detect a statistically significant difference, and 80 individuals were recruited to allow for 20% attrition.
“Using the effect size of 0.52, we determined that n=64 would have 80% and 83% power (two-sided type I error) to detect a statistically significant difference in changes non-reactivity scores and WRSD respectively. To account for 20% attrition, we recruited 80 individuals with worry interfering with sleep.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [9] source
The cited paper’s Discussion (page unavailable) reports a Cohen’s d of 1.06 for change in anxiety, but does not report the claimed 0.52 effect size. Its Results (page unavailable) describe 89 enrolled participants, not a power calculation for non-reactivity or worry-related sleep disturbance. Searches for 0.52, those outcomes, sample-size power, and attrition found no passage addressing the claim. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductcitationThe study was approved by the Brown University Institutional Review Board and pre-registered at ClinicalTrials.gov, with a published protocol paper.
“The study was approved by the Brown University Institutional Review Board and study design, statistical analyses, and outcomes were pre-registered at ClinicalTrials.gov in addition to the publication of a protocol paper (22).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [22] source
The cited work is a published study protocol, but its Methods > Monitoring section says Brown University IRB approval 'will be obtained' before enrollment, not that it had already been granted. Measurements > Open Science approach likewise says the study 'will preregister' on ClinicalTrials.gov; it does not establish that the design, analyses, and outcomes had already been preregistered. (LLM, conf=0.91)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S2 (checkable).
PremisecitationMindfulness is a form of mental training that increases interoceptive awareness to reduce reactivity to stress.
“mindfulness is a form of mental training that increases interoceptive awareness to reduce reactivity to stress (10,11).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [10]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [11] source
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing). May combine two claims.
PremisecitationA relatively low-cost mobile application can be widely disseminated and may increase treatment access and utilization, especially among underserved populations.
“Accessibility is an important area of future study: a relatively low-cost mobile application can be widely disseminated and may increase treatment access and utilization especially among underserved populations (44–46).”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [44]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [45] source
Recommendation 7 (page unavailable) says new technologies may increase the reach and access of mindfulness-based interventions and that technology-driven formats may aid dissemination. It does not specifically address a low-cost mobile application, increased treatment utilization, or benefits especially for underserved populations. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [46] source
May combine two claims.
Findingown dataIn a modified intent-to-treat analysis, worry-related sleep disturbance scores fell by 27% in the TAU+MT group and 6% in the TAU group at 2 months, with median change 11 versus 15 and P = .001.
“In a modified intent-to-treat analysis, WRSD scores decreased by 27% in TAU+MT (n=36) and 6% in TAU (n=35) at 2 months (median [IQR] change: 11 [4.3] v. 15 [5.0], P = .001).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTAU + MT (n=24) reported an average increase in SPT from 452 to 458 minutes, while TAU (n=30) reported no change (464 minutes).
“TAU + MT (n=24) reported an average increase in SPT from 452 to 458 minutes compared to TAU (n=30) who reported no change (464 minutes).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn the complete-case analysis (46 participants), findings for TST corroborated the imputed-data analysis (P = .86), but a significant between-group difference was found in SE with 97% in TAU + MT and 96% in TAU (P = .04).
“46 participants were included in the CC analysis which corroborated the findings from the analysis with imputed data for TST (P = .86) however a significant between-group difference was found in SE with 97% in the TAU + MT group and 96% in TAU (P = .04; see Appendix 3, Supplemental Digital Content 3).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataAverage and median estimated sleep durations were greater than 7 hours at all time points in both groups.
“Average and median estimated sleep durations were > 7 hours at all time points in both groups.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAfter imputing missing data, no significant between-group differences were found in average estimated TST or SE at 2 months post treatment initiation (P = .52; P = .70).
“After imputing missing data, no significant between-group differences were found in average estimated TST or SE at 2 months post treatment initiation (P = .52; P = .70).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSE remained the same in TAU + MT (96%) while it increased from 95% to 96% in TAU.
“SE remained the same in TAU + MT (96%) while it increased from 95% to 96% in TAU.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataTime was not significantly associated with a change in non-reactivity scores for the TAU + MT group at 1 month but was at 2 months.
“Interestingly, time was not significantly associated with a change in non-reactivity scores for the TAU + MT group at 1 month but it was at 2 months.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe randomization schema was generated by an independent statistician in variable blocks of four and six.
“The randomization schema was generated by an independent statistician in variable blocks of four and six.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductcitationA consumer Fitbit device was chosen instead of a research-grade actigraph because it represents what individuals can access, though this trades accuracy and precision for convenience and lower participant burden.
“This consumer device was selected rather than a research-grade actigraph because it is most representative of what individuals can access for personal use. While there is a trade-off in terms of accuracy and precision in sleep measurement, consumer devices provide the benefit of convenience and reduce participant burden (34).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] source
May combine two claims.
PremisecitationA small number of mindfulness-based interventions have shown varying efficacy for treating sleep disturbance, and few used randomized controlled trial designs.
“A small number of MBIs have shown varying degrees of efficacy for treating sleep disturbance, though few used randomized controlled trial designs (15).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] source
May combine two claims.
PremisecitationSleep-specific worry predicts both sleep disturbance and sleep-related impairment even after controlling for demographics, chronotype, and overall health status.
“Sleep-specific worry predicts both sleep disturbance and sleep-related impairment even after controlling for demographics, chronotype, and overall health status (4).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [4] source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataSeventy-one participants were included in the intention-to-treat analysis.
“71 participants were included in the ITT analysis (see CONSORT diagram, Figure 1).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataAnalyses used an intent-to-treat approach.
“Analyses were conducted in R (v.4.0.2) using an intent-to-treat approach (ITT).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenThe person randomizing participants and conducting assessments was not involved in data analysis, and the principal investigator, statistician, and data analysts were blinded until all analyses were complete.
“The individual responsible for randomization of participants and conducting the assessments was not involved in data analysis. The Principal Investigator, statistician, and individuals conducting data analysis were blinded until all analyses were complete.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCognitive behavioral treatment of insomnia is an effective therapy that targets cognitions and maladaptive behaviors associated with coping with poor sleep.
“cognitive behavioral treatment of insomnia (CBT-I) is an effective therapy that targets cognitions and maladaptive behaviors associated with coping with poor sleep (16)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe Penn State Worry Questionnaire is a validated 16-item questionnaire for assessing worry.
“The PSWQ is a 16-item questionnaire validated to assess worry (29).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [29] source
May combine two claims.
InterpretationreasoningApp-based mindfulness training can be disseminated widely and may mechanistically target worry, disrupting cognitive processes that lead to emotional distress and heightened physiological arousal that may drive insomnia.
“A potential advantage of app-based MT for sleep disturbances related to anxiety and worry is that it can be disseminated widely and may mechanistically target worry, disrupting cognitive processes that lead to emotional distress and heightened physiological arousal that may ultimately drive insomnia.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductown dataThe study was a parallel group randomized controlled trial.
“This was a parallel group randomized controlled trial.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataGender was included as a covariate in all generalized estimating equation models because of a significant baseline between-group difference.
“Due to a significant between-group difference at baseline, gender was included as a covariate in all GEE models.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe non-reactivity subscale of the Five Facet Mindfulness Questionnaire is validated for independent use to assess emotional reactivity.
“The non-reactivity subscale is validated for use independently and is composed of 7 questions from the 39-item FFMQ (30).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningAverage estimated total sleep time was calculated only for participants with at least 3 days recorded during the wear period to improve reliability.
“To improve reliability, average estimated TST was calculated for participants with ≥ 3 days recorded during the wear period.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataAllocation was concealed using opaque, sealed envelopes prepared, reviewed, and sealed by two individuals independent of the research team.
“participants received an opaque, sealed envelope which contained their group assignment to treatment-as-usual (TAU) or TAU + MT (1:1 ratio). The envelopes were prepared, reviewed, and sealed by two individuals independent of the research team.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataMissing Fitbit and paper sleep diary data were found to be missing completely at random, and multiple imputation created five datasets to correct for bias from missing data.
“The missing data for both Fitbit and PSDs were found to be missing completely at random and multiple imputation was used to create five imputed datasets to correct for any bias introduced by missing data.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe study results demonstrate a mechanistic link between mindfulness training and increased emotional non-reactivity, decreased worry, and reduced reported sleep disturbances.
“Results from this study demonstrate a mechanistic link between MT and increased emotional non-reactivity, decreased worry, and reduction in reported sleep disturbances”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationStress-related worry may exacerbate sleep reactivity, which can cause consistent sleep responses to stress over time regardless of stimuli and increase the risk of developing insomnia.
“Stress-related worry may exacerbate sleep reactivity, which can cause consistent sleep responses to stress over time regardless of stimuli, thus increasing the risk of developing insomnia (8).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationRisk of bias was assessed with the Cochrane Collaboration's tool across seven domains.
“Using the Cochrane Collaboration’s tool for evaluating risk of bias, we assessed potential bias across seven domains: random sequence generation, allocation concealment, blinding of participants and researchers, blinding of outcome assessment, incomplete outcome data, selective reporting, and other bias (41).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] source
May combine two claims.
Interpretationown dataThe mediation models align with mindfulness theory and are suggestive of a treatment mechanism that can more precisely facilitate the process of improving sleep disturbance.
“The mediation models align with mindfulness theory and are suggestive of a treatment mechanism that can more precisely facilitate the process of improving sleep disturbance.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationConcerns about disturbed sleep stemming from people monitoring their sleep on wearable devices and believing device data over more validated and accurate measures has led to the description of orthosomnia, a sleep disorder based on worry about sleep.
“Indeed, concerns about disturbed sleep stemming from people monitoring their sleep on wearable devices and believing device data over more validated and accurate measures (e.g. believing a wearable over an overnight sleep study conducted by a certified lab and interpreted by a licensed sleep medicine physician) has led to the description of orthosomnia, a sleep disorder based on worry about sleep”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [49]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenMBI studies benefit from comparison to TAU or an intervention with similar cognitive effort, though it is often difficult to find appropriate active controls.
“Finally, MBI studies benefit from comparison to TAU or an intervention with similar cognitive effort, though it is often difficult to find appropriate active controls.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA recent study found 125 million new wearable devices were shipped worldwide over a 3-month period in 2020.
“A recent study found 125 million new wearable devices were shipped worldwide over a 3-month period in 2020 (48).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [48]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Interpretationown dataParticipants did not report reductions in time in bed (sleep period time) as would be expected in patients employing CBT-I, supporting the notion that the MT intervention works to improve sleep through a different mechanism than CBT-I.
“Moreover, our participants did not report reductions in time in bed (sleep period time) as would be expected in patients employing CBT-I, supporting the notion that our MT intervention works to improve sleep through a different mechanism than CBT-I.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataMT reduced worry, and increases in non-reactivity accounted for 49% of this effect.
“Taken together, these findings indicate that MT reduced worry and increases in non-reactivity accounted for 49% of this effect, suggesting that one mechanism by which participants’ worry decreased was their ability to not get caught up in thoughts and emotions.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataApp-based MT effectively increased non-reactivity with concomitant decreases in self-reported worry and worry-disrupted sleep.
“This study provides evidence for this mechanism, as app-based MT effectively increased non-reactivity with concomitant decreases in self-reported worry and worry disrupted sleep.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataMT effectively reduced worry and decreased self-reported worries about sleep but showed no significant effect on quantitative measures of sleep duration.
“We found that MT effectively reduced worry and decreased self-reported worries about sleep but showed no significant effect on quantitative measures of sleep duration.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataIncreases in non-reactivity mediated reductions in worry, and reductions in worry mediated reductions in WRSD.
“From a mechanistic perspective, we found that increases in non-reactivity mediated reductions in worry and reductions in worry mediated reductions in WRSD.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe study demonstrates clinical efficacy and full mediation of the effects of MT on perceived sleep disturbances by worry.
“Our study demonstrates clinical efficacy and full mediation of the effects of MT on perceived sleep disturbances by worry.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataMT reduced WRSD, and reductions in worry accounted for 53% of this effect.
“Taken together, these findings indicate that MT reduced WRSD and reductions in worry accounted for 53% of this effect, suggesting that one mechanism by which participants’ WRSD decreased was their ability to decrease hyperarousal through learned non-reactivity.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA cited limitation of the current body of research on MBIs is the narrow focus on novel and/or clinical populations.
“It is important to note that a cited limitation of the current body of research on MBIs is the narrow focus on novel and/or clinical populations (47).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] source
May combine two claims.
InterpretationreasoningThe results of the current study provide additional support for the existence of a dose-response and/or sleeper effect.
“The results of the current study provide additional support for the existence of a dose-response and/or sleeper effect.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationThe field of mindfulness research has received criticism for lack of reproducibility; few MBIs surpass Stage 0 or I of the NIH stage model, and less than 2% reach the stage of effectiveness or implementation/dissemination research.
“The field of mindfulness research has received criticism for lack of reproducibility. Few MBIs surpass Stage 0 or I of the stage model established by the National Institutes of Health (NIH) for clinical science and less than 2% reach the stage of effectiveness or implementation/dissemination research (47).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [47] source
May combine two claims.
PremisecitationFitbit devices exhibit better sensitivity than specificity, as they overestimate TST and underestimate restlessness.
“However, it has been shown that Fitbit devices exhibit better sensitivity than specificity, as they overestimate TST and underestimate restlessness (50,51).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [50]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [51]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Interpretationown dataThe lack of effect on quantitative sleep duration may be due to a combination of Fitbit device limitations and a ceiling effect: sleep efficiency calculated from Fitbit data was 96% at baseline for both groups, mirroring the relatively high sleep durations reported on baseline sleep diaries.
“This may be due to a combination of Fitbit device limitations and the existence of a ceiling effect: sleep efficiency calculated from Fitbit data was 96% at baseline for both groups, mirroring the relatively high sleep durations that participants in both groups reported on their baseline sleep diaries.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataMT reduced worry and anxiety and decreased self-reported worries about sleep, with the effect first observed between groups and then replicated within the study when the control group received the active intervention.
“We found that MT reduced worry and anxiety and decreased self-reported worries about sleep – an effect that was first observed between groups and then replicated within the study when the control group received the active intervention.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenConsumer devices are most reflective of what the study demographic would use on a personal basis to track sleep duration and quality.
“Consumer devices are also most reflective of what our study demographic would use on a personal basis to track sleep duration and quality.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Fitbit-derived estimates of total sleep time and sleep efficiency are accurate enough to detect between-group differences in sleep outcomes.
“Fitbit devices were used to estimate total sleep time (TST) as well as total time awake and bed/wake times using the device’s sleep algorithms.”
“While there is a trade-off in terms of accuracy and precision in sleep measurement, consumer devices provide the benefit of convenience and reduce participant burden (34).”
The paper relies on this without support.
This is the first randomized controlled trial to evaluate the efficacy of app-based mindfulness training for improving anxiety-related sleep disturbance.
“To our knowledge, this is the first RCT to evaluate the efficacy of app-based MT in improving anxiety-related sleep disturbance.”
The paper relies on this without support.
Sleep-related worry imposes a large burden on the U.S. population and represents an unmet public health need.
“The immense burden of sleep-related worry on the overall U.S. population constitutes an unmet public health need.”
The paper relies on this without support.
Sleep disturbances and worry about sleep affect many people at a severity that does not always warrant a clinical diagnosis.
“To conclude, sleep disturbances and worry about sleep affect a broad range of individuals at a severity that may not always warrant clinical diagnosis.”
The paper relies on this without support.
Making digital therapeutics such as app-based mindfulness training available to the general population improves preventive treatment-seeking behavior.
“Making digital therapeutics like app-based MT available to the general population serves to improve preventive treatment-seeking behavior.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
TAU can be quite minimal or fairly extensive.
“For example, TAU can be quite minimal (e.g., permission to pursue treatment outside of the study, referrals to non-study-related providers)19 or fairly extensive (e.g., receipt of pharmacotherapy and/or psychotherapy)20–22.”
From Selecting and describing control conditions in mobile health randomized controlled trials: a proposed typology (2023) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
TAU baseline sleep efficiency is reported as both 95% and 96%
MinorThe Fitbit results give TAU a baseline sleep efficiency of 95%, while the discussion says it was 96% in both groups.
“SE remained the same in TAU + MT (96%) while it increased from 95% to 96% in TAU.”
“sleep efficiency calculated from Fitbit data was 96% at baseline for both groups”
Four-month completion percentage uses the wrong denominator
MinorThe stated 22 of 36 participants equals 61%, not 73%.
Reported 73 · recomputed 61.111111
“which increased to 73% (22/36) at 4 months.”
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“The same procedure was followed to explore within-group change for TAU after they received the intervention, and multiple comparisons were adjusted for using the false discovery rate (35).”
MethodBaron, R. M., & Kenny, D. A. (1986) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.51.6.1173 · Cited by 91,532 · cited 2×
“Mediation analyses were conducted using the Baron and Kenny (37) four-step approach in addition to causal mediation models (38).”
MethodThe Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765 · cited 2×
“Total scores of 5, 10, and 15 serve as the cutoff points distinguishing mild, moderate, and severe anxiety, respectively (31).”
BackgroundMethodLongitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550 · cited 1×
“GEEs are used for longitudinal data to account for within-subject covariance over time (36).”
MethodMindfulness: A proposed operational definition.
Bishop, S. R., Lau, M., Shapiro, S., Carlson, L., Anderson, N. D., Carmody, J., Segal, Z. V., Abbey, S., Speca, M., Velting, D., et al. (2004) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy.bph077 · Cited by 7,234
Merikangas, K. R., He, J.-P., Burstein, M., Swanson, S. A., Avenevoli, S., Cui, L., Benjet, C., Georgiades, K., & Swendsen, J. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.05.017 · Cited by 6,278 · cited 1×
“Approximately 1 in 3 US adults experience an anxiety disorder at some point in their lives (6).”
BackgroundDevelopment and validation of the Penn State Worry Questionnaire
Meyer, T. J., Miller, M. L., Metzger, R. L., & Borkovec, T. D. (1990) · Behaviour Research and Therapy · doi:10.1016/0005-7967(90)90135-6 · Cited by 5,099 · cited 9×
“We fit two mediation models: a) model A explored the effects of MT on reduction in worry at 2 months mediated by changes in nonreactivity at 1 and 2 months, and b) model B explored the effects of MTon reduction in WRSD (PROMIS) at 2 months mediated by changes in worry (PSWQ) at 1 and 2 months.”
MethodInfluentialAnxiety disorders in primary care: prevalence, impairment, comorbidity, and detection
Kroenke, K., Spitzer, R. L., Williams, J. B. W., Monahan, P. O., & Löwe, B. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00004 · Cited by 4,741 · cited 1×
“The GAD-7 is a validated seven-item questionnaire used clinically to screen for GAD and assess symptom severity (sensitivity of 89%, specificity of 82%) (33).”
MethodBaer, R. A., Smith, G. T., Lykins, E., Button, D., Krietemeyer, J., Sauer, S., Walsh, E., Duggan, D., & Williams, J. M. G. (2008) · Assessment · doi:10.1177/1073191107313003 · Cited by 2,930 · cited 4×
“The nonreactivity subscale is validated for use independently and is composed of 7 questions from the 39-item FFMQ (30).”
MethodInfluentialGu, J., Strauss, C., Bond, R., & Cavanagh, K. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.01.006 · Cited by 1,712 · cited 1×
“Mindfulness training (MT) increases metacognitive awareness, which is defined as the ability to monitor and control one’s own cognition to disrupt cycles of worry (12).”
BackgroundDetecting and monitoring depression with a two-item questionnaire (PHQ-2)
Löwe, B., Kroenke, K., & Gräfe, K. (2005) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2004.09.006 · Cited by 1,473 · cited 1×
“We excluded potential participants who reported: a) changing the dose of psychotropic medication in the past 2 months; b) as-needed use of a hypnotic sleep aid and/or benzodiazepines; c) known sleep disorder; d) psychotic disorder; e) current diagnosis of posttraumatic stress disorder; f ) score ≥3 on the two-item Pat…”
BackgroundYu, L., Buysse, D. J., Germain, A., Moul, D. E., Stover, A., Dodds, N. E., Johnston, K. L., & Pilkonis, P. A. (2012) · Behavioral Sleep Medicine · doi:10.1080/15402002.2012.636266 · Cited by 1,241 · cited 2×
“The primary outcome was change in WRSD, measured using five PatientReported Outcomes Measurement Information System (PROMIS) sleep disturbance items that were preselected based on their direct assessment of worry interfering with sleep (28).”
MethodMediation analysis with multiple mediators
VanderWeele, T., & Vansteelandt, S. (2014) · Epidemiologic Methods · doi:10.1515/em-2012-0010 · Cited by 858
Buysse, D. J., Yu, L., Moul, D. E., Germain, A., Stover, A., Dodds, N. E., Johnston, K. L., Shablesky-Cade, M. A., & Pilkonis, P. A. (2010) · Sleep · doi:10.1093/sleep/33.6.781 · Cited by 850
Interactions Between Obesity and Obstructive Sleep Apnea
Romero‐Corral, A., Caples, S. M., López-Jiménez, F. A., & Somers, V. K. (2010) · CHEST Journal · doi:10.1378/chest.09-0360 · Cited by 818 · cited 1×
“We excluded potential participants who reported: a) changing the dose of psychotropic medication in the past 2 months; b) as-needed use of a hypnotic sleep aid and/or benzodiazepines; c) known sleep disorder; d) psychotic disorder; e) current diagnosis of posttraumatic stress disorder; f ) score ≥3 on the two-item Pat…”
BackgroundKalmbach, D. A., Anderson, J. R., & Drake, C. L. (2018) · Journal of Sleep Research · doi:10.1111/jsr.12710 · Cited by 620 · cited 1×
“Stressrelated worry may exacerbate sleep reactivity, which can cause consistent sleep responses to stress over time regardless of stimuli, thus increasing the risk of developing insomnia (8).”
BackgroundInterpretation and identification of causal mediation
Pearl, J. (2014) · Psychological Methods · doi:10.1037/a0036434 · Cited by 554 · cited 1×
“In the causal mediation analysis, we focused on the natural direct and indirect effects and used the bootstrap method with 1000 bootstrapped resamples to compute the standard errors and 95% confidence interval (CI) (39,40).”
MethodHoge, E. A., Bui, E., Marques, L., Metcalf, C. A., Morris, L. K., Robinaugh, D. J., Worthington, J. J., Pollack, M. H., & Simon, N. M. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m08083 · Cited by 511 · cited 2×
“A prior study of mindfulness-based stress reduction for individuals with anxiety was used to determine the sample size for this study (9).”
BackgroundMethodSelf-citationGregory, A. M., Caspi, A., Eley, T. C., Moffitt, T. E., O’Connor, T. G., & Poulton, R. (2005) · Journal of Abnormal Child Psychology · doi:10.1007/s10802-005-1824-0 · Cited by 479 · cited 1×
“Links between disrupted sleep and anxiety seem to be bidirectional; that is, persistent sleep disturbance predicts the development of anxiety disorders (2,3), and worry plays a major role in increasing bedtime arousal and perceived sleep disturbances (4).”
BackgroundAccuracy of Wristband Fitbit Models in Assessing Sleep: Systematic Review and Meta-Analysis
Haghayegh, S., Khoshnevis, S., Smolensky, M. H., Diller, K. R., & Castriotta, R. J. (2019) · Journal of Medical Internet Research · doi:10.2196/16273 · Cited by 446 · cited 1×
“However, it has been shown that Fitbit devices exhibit better sensitivity than specificity, as they overestimate TST and underestimate restlessness (50,51).”
BackgroundA systematic review of sleep disturbance in anxiety and related disorders
Cox, R. C., & Olatunji, B. O. (2016) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2015.12.001 · Cited by 395 · cited 2×
“Moreover, anxiety-specific treatments are less effective when sleep disturbance is not addressed (3).”
BackgroundKoffel, E., Bramoweth, A. D., & Ulmer, C. S. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4390-1 · Cited by 391 · cited 1×
“Although CBT-I is a prominent nonpharmacological treatment for insomnia, MT differs in mechanism: CBT-I generally focuses on regularizing sleep cycles through implementation of behavioral changes and identifying, challenging, and replacing negative perceptions that impair sleep (42), whereas MT may help an individual…”
BackgroundMindfulness training for smoking cessation: Results from a randomized controlled trial
Brewer, J. A., Mallik, S., Babuscio, T. A., Nich, C., Johnson, H. E., Deleone, C. M., Minnix-Cotton, C. A., Byrne, S. A., Kober, H., Weinstein, A. J., et al. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.05.027 · Cited by 383
Self-citationImproving sleep with mindfulness and acceptance: a metacognitive model of insomnia
Ong, J. C., Ulmer, C. S., & Manber, R. (2012) · Behaviour Research and Therapy · doi:10.1016/j.brat.2012.08.001 · Cited by 376 · cited 3×
“Improving one’s ability to maintain emotional nonattachment from unfavorable sleep outcomes throughmindfulness practice addresses the metacognitive component of sleep-related arousal (11,13,14).”
BackgroundBehar, E., Alcaine, O., Zuellig, A. R., & Borkovec, T. D. (2003) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/s0005-7916(03)00004-1 · Cited by 373 · cited 9×
“Psychosomatic Medicine, V 84 • 632-642 636 Copyright © 2022 by the American Psychosomatic Society. in GAD-7 score compared with an increase of 17% in TAU.”
BackgroundInfluentialShapiro, S. L., Bootzin, R. R., Figueredo, A. J., Lopez, A. M., & Schwartz, G. E. (2003) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00546-9 · Cited by 350
Prospects for a clinical science of mindfulness-based intervention
Dimidjian, S., & Segal, Z. V. (2015) · American Psychologist · doi:10.1037/a0039589 · Cited by 291 · cited 2×
“It is important to note that a cited limitation of the current body of research on MBIs is the narrow focus on novel and/or clinical populations (47).”
BackgroundOng, J. C., Shapiro, S. L., & Manber, R. (2008) · Behavior Therapy · doi:10.1016/j.beth.2007.07.002 · Cited by 268
Wearable devices in clinical trials: hype and hypothesis
Izmailova, E. S., Wagner, J. A., & Perakslis, E. D. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.966 · Cited by 265 · cited 1×
“Although there is a trade-off in terms of accuracy and precision in sleep measurement, consumer devices provide the benefit of convenience and reduce participant burden (34).”
BackgroundGarbarino, S., Lanteri, P., Durando, P., Magnavita, N., & Sannita, W. G. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13080831 · Cited by 202
Orthosomnia: are some patients taking the quantified self too far?
Baron, K. G., Abbott, S., Jao, N., Manalo, N., & Mullen, R. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6472 · Cited by 188 · cited 1×
“, believing a wearable over an overnight sleep study conducted by a certified laboratory and interpreted by a licensed sleep medicine physician) have led to the description of orthosomnia, a sleep disorder based on worry about sleep (49).”
BackgroundInsomnia as a Transdiagnostic Process in Psychiatric Disorders
Dolsen, E. A., Asarnow, L. D., & Harvey, A. G. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0471-y · Cited by 163
Garrison, K. A., Pal, P., O’Malley, S. S., Pittman, B. P., Gueorguieva, R., Rojiani, R., Scheinost, D., Dallery, J., & Brewer, J. A. (2020) · Nicotine and Tobacco Research · doi:10.1093/ntr/nty126 · Cited by 155
Self-citationGrella, C. E., Greenwell, L., Mays, V. M., & Cochran, S. D. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-52 · Cited by 145
Cognitive behavioral treatment of insomnia
Williams, J., Roth, A., Vatthauer, K., & McCrae, C. S. (2013) · Chest · doi:10.1378/chest.12-0731 · Cited by 123
Moreno-Pino, F., Porras-Segovia, A., López-Esteban, P., Artés, A., & Baca-García, E. (2019) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.8032 · Cited by 112
Mason, A. E., Jhaveri, K., Cohn, M., & Brewer, J. A. (2018) · Journal of Behavioral Medicine · doi:10.1007/s10865-017-9884-5 · Cited by 106
Self-citationBrewer, J. A., Ruf, A., Beccia, A. L., Essien, G. I., Finn, L. M., Lutterveld, R. V., & Mason, A. E. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.01418 · Cited by 82
Self-citationHuberty, J. L., Green, J., Puzia, M. E., Larkey, L., Laird, B., Vranceanu, A.-M., Vlisides-Henry, R., & Irwin, M. R. (2021) · PLOS ONE · doi:10.1371/journal.pone.0244717 · Cited by 73 · cited 1×
“Improving one’s ability to maintain emotional nonattachment from unfavorable sleep outcomes throughmindfulness practice addresses the metacognitive component of sleep-related arousal (11,13,14).”
BackgroundA Meta-Analysis of Mindfulness-Based Therapies for Insomnia and Sleep Disturbance
Rash, J. A., Kavanagh, V. A. J., & Garland, S. N. (2019) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2019.01.004 · Cited by 70 · cited 1×
“A small number of MBIs have shown varying degrees of efficacy for treating sleep disturbance, although few used randomized controlled trial designs (15).”
BackgroundWorried sleep: 24-h monitoring in high and low worriers
Weise, S., Ong, J., Tesler, N. A., Kim, S., & Roth, W. T. (2013) · Biological Psychology · doi:10.1016/j.biopsycho.2013.04.009 · Cited by 62 · cited 1×
“High levels of worry predict more sleep problems such as increased nocturnal awakenings and lower sleep efficiency (SE) (7).”
BackgroundEthnicity and mental health treatment utilization by patients with personality disorders.
Bender, D. S., Skodol, A. E., DYCK, I. R., Markowitz, J. C., Shea, M. T., Yen, S., Sanislow, C. A., Pinto, A., Zanarini, M. C., McGlashan, T. H., et al. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.6.992 · Cited by 43
Roy, A., Hoge, E. A., Abrante, P., Druker, S., Liu, T., & Brewer, J. A. (2021) · Journal of Medical Internet Research · doi:10.2196/26987 · Cited by 41 · cited 10×
“Psychosomatic Medicine, V 84 • 632-642 636 Copyright © 2022 by the American Psychosomatic Society. in GAD-7 score compared with an increase of 17% in TAU.”
MethodInfluentialSelf-citationA step towards stepped care: delivery of CBT-I with reduced clinician time
Manber, R., Simpson, N. S., & Bootzin, R. R. (2015) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2014.09.003 · Cited by 32 · cited 1×
“For instance, cognitive behavioral treatment of insomnia (CBT-I) is an effective therapy that targets cognitions and maladaptive behaviors associated with coping with poor sleep (16), but lack of trained practitioners limits patient access (17).”
BackgroundUse of Outpatient Mental Health Services by Depressed and Anxious Children as They Grow Up
Goldstein, R. B., Olfson, M., WICKRAMARATNE, P. J., & Wolk, S. I. (2006) · Psychiatric Services · doi:10.1176/ps.2006.57.7.966 · Cited by 17
Worry and rumination have distinct associations with nighttime versus daytime sleep symptomology
Tutek, J., Gunn, H. E., & Lichstein, K. L. (2021) · Behavioral Sleep Medicine · doi:10.1080/15402002.2020.1725012 · Cited by 16
Brewer, J. A., Roy, A., Deluty, A., Liu, T., & Hoge, E. A. (2020) · Health Psychology · doi:10.1037/hea0000874 · Cited by 16 · cited 2×
“TheMTwas delivered through an app-based platform, UnwindingAnxiety, which includes 30 core modules and 8 “theme weeks” (that reinforce core concepts) of brief didactic and experience-based MT (videos and animations, ~10 min/day), app-initiated check-ins and other ecological momentary assessment (EMA) tools, user-initi…”
BackgroundMethodSelf-citation
Flagged first, then by citations
2 of the 50 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Goldberg, S. B., Sun, S., Carlbring, P., & Torous, J. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00923-7 · Cited by 75
Linardon, J., Messer, M., Goldberg, S. B., & Fuller‐Tyszkiewicz, M. (2023) · Clinical Psychology Review · doi:10.1016/j.cpr.2023.102370 · Cited by 78
Linardon, J. (2023) · Behaviour Research and Therapy · doi:10.1016/j.brat.2023.104421 · Cited by 69
Systematic review and meta-analysis of adverse events in clinical trials of mental health apps
Linardon, J., Fuller-Tyszkiewicz, M., Firth, J., Goldberg, S. B., Anderson, C., McClure, Z., & Torous, J. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01388-y · Cited by 44
The impact of mindfulness apps on psychological processes of change: a systematic review
Macrynikola, N., Mir, Z., Gopal, T., Rodriguez, E., Li, S., Cox, M., Yeh, G. Y., & Torous, J. B. (2024) · npj Mental Health Research · doi:10.1038/s44184-023-00048-5 · Cited by 36
“Three studies found an effect favoring the intervention group, with small to large effect sizes 45,46,53 , and one of these had an active control group 53 .”
Zainal, N. H., & Newman, M. G. (2023) · European Psychiatry · doi:10.1192/j.eurpsy.2023.2 · Cited by 26
“Mindfulness theories posit that persistently exercising present-moment awareness, acceptance, and related skills reduces suboptimal stress reactivity [7, 8].”
Fuhrmann, L. M., Weisel, K. K., Harrer, M., Kulke, J. K., Baumeister, H., Cuijpers, P. J., Ebert, D. D., & Berking, M. (2023) · Internet Interventions · doi:10.1016/j.invent.2023.100703 · Cited by 27
“Anxiety symptoms as primary outcome were targeted in three comparisons (Boettcher et al., 2018; Gao et al., 2022; Roy et al., 2021) and revealed a significant pooled effect size of g = 0.80 (95 %; CI 0.06 to 1.54, p = 0.033; see Appendix F for forest plot Fig.”
InfluentialAdherence to CPAP Treatment: Can Mindfulness Play a Role?
Pataka, A., Kotoulas, S., Gavrilis, P. R., Karkala, A., Tzinas, A., & Stefanidou, A. (2023) · Life · doi:10.3390/life13020296 · Cited by 20
“, Calm app is one app that specializes in audio and video programs intended to help someone relax before bedtime) and could be a viable option to help patients with OSA reduce self-reported anxiety and get a high-quality sleep [83,84].”
BackgroundThe meditation app revolution.
Creswell, J. D., & Goldberg, S. B. (2025) · American Psychologist · doi:10.1037/amp0001576 · Cited by 18
“Emerging research suggests that app-based interventions yield reductions in worry, repetitive negative thinking, and stress reactivity —mechanisms that have been widely studied in traditional in-person programs (Gao et al., 2022; Roy et al., 2021).”
Vargas-Nieto, J. C., Zambrano, D., Montorio, I., & Pineda, L. M. S. (2024) · Mindfulness · doi:10.1007/s12671-024-02321-w · Cited by 17
“…changes in the measures of psychological distress and quality of life (Cillessen et al., 2018; Goldberg et al., 2020), sleep-related problems (Gao et al., 2022), increased social connectedness, self-reflection, insight and defusion (Goldberg et al., 2020), emotional regulation and…”
InfluentialLinardon, J., Anderson, C., McClure, Z., Liu, C., & Messer, M. (2024) · Sleep Medicine · doi:10.1016/j.sleep.2024.08.025 · Cited by 13
Lee, S.-A., & Park, J. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-02120-0 · Cited by 5
“However,moststudiescombinedDMBIswithadjunctive elements(e.g.,sleephygieneorcognitivetherapy) 23,24 , obscuring their independent effects.”
Zhang, B., Li, Y., Chu, W., Li, Y., Zhang, J., Lv, Z., Luo, Y., & Chen, Y. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1669888 · Cited by 3
Digital Mindfulness Training for Burnout Reduction in Physicians: Clinician-Driven Approach
Antico, L., & Brewer, J. (2025) · JMIR Formative Research · doi:10.2196/63197 · Cited by 3
“In addition, this intervention contributes to the growing field of digital therapeutics by demonstrating clinically meaningful effects [7,60,61,84].”
Self-citationValentine, L., Hinton, J. D. X., Bajaj, K., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-5302304/v1 · Cited by 1
Cao, Y., Huang, S., Kong, S., Yang, Y., & Xie, W. (2026) · Internet Interventions · doi:10.1016/j.invent.2026.100967
Chu, X. (2026) · Journal of medicine and physical education. · doi:10.62517/jmpe.202618204
Pham, K., Penberthy, J. M., Boyd, O., & Christopher, M. (2026) · Research Square · doi:10.21203/rs.3.rs-7926560/v1
Wu, X., Wang, W., Wang, Y., Xue, Y., Zhao, H., Liu, J., & Peng, Y. (2026) · Current Psychology · doi:10.1007/s12144-026-09040-6
“( Gao et al., 2022; Tadros et al., 2025 ).”
Carpati, A., Plutchik, J., Schupak, M., & Sala, M. (2026) · doi:10.2196/preprints.90730
Carpati, A., Plutchik, J., Schupak, M., & Sala, M. (2026) · Journal of Medical Internet Research · doi:10.2196/90730
Meta-Analysis on the Effectiveness of mHealth Interventions for Mental Health: A 10-Year Update
Tomlinson, C. S., Toevs, E. K., Gallagher, H. T., Angus, A., & Lindhiem, O. J. (2025) · Behavior Modification · doi:10.1177/01454455251380218 · Cited by 1
Tultabayev, M., Zhumanova, U., Tultabayeva, T., & Shoman, A. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1626046
“…over 3 months; improvement in cognitive functions by 20–30% (per TMT and Stroop tests) over 12 weeks; reduction in anxiety by 30–40% over 8 weeks; improvement in sleep quality by 25–35% over 2 months; and reduction in cortisol levels by 15–20% and inflammatory markers (e.g., IL-6) by 10–15% (41).”
Shepherd, W. S., Schadegg, M., & Dixon, L. J. (2025) · Psychiatric quarterly · doi:10.1007/s11126-025-10160-8 · Cited by 1
“Additionally, similar to the first approach, mindfulness training, which focuses on increasing awareness of internal experiences and overall disrupting cycles of worry, has found to be effective in reducing worry and consequently, improving sleep outcomes Gao et al., [32].”
Antico, L., & Brewer, J. (2024) · doi:10.2196/preprints.63197 · Cited by 3
Self-citation
- Authors
- Gao, M., Roy, A., Deluty, A., Sharkey, K. M., Hoge, E. A., Liu, T., & Brewer, J. A.
- Affiliations
- Brown University (US)
- Corresponding author
- Brewer, Judson A.
- Venue
- Psychosomatic Medicine
- Published
- 2022-04-14
- Volume
- 84
- Issue
- 5
- Pages
- 632-642
- ISSN
- 0033-3174 (ISSN-L)
- 1534-7796
- PMC
- PMC9167766
- OpenAlex
- W4223903862
- Cited by
- 24
- References
- 50
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 5 · 2023: 6
- FWCI
- 4.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Psychosomatic Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R21AG062004)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Keywords
- mindfulness training, sleep disorders, anxiety, worry, mobile health apps, digital mental health interventions, sleep efficiency, total sleep time, mediation analysis, Fitbit
- MeSH terms
- Anxiety, Anxiety Disorders, Humans, Sleep, Sleep Wake Disorders, Mobile Applications, Mindfulness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read under definition version 3 (extract-v3) on 2026-09-28.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-28.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review